Acetyl-Histone H2A (Lys5) Antibody

What is Acetyl-Histone H2A (Lys5) Antibody and what biological significance does histone H2A lysine 5 acetylation have?

Acetyl-Histone H2A (Lys5) Antibody is a specialized research reagent that specifically recognizes histone H2A proteins acetylated at the lysine 5 residue. This post-translational modification plays a crucial role in epigenetic regulation. Histone acetylation generally promotes a more open chromatin structure by neutralizing the positive charge of lysine residues, thereby weakening histone-DNA interactions and facilitating transcription factor binding. The acetylation of histone H2A at lysine 5 (H2AK5ac) is specifically associated with transcriptionally active chromatin regions and gene activation. This modification is part of the complex histone code that orchestrates gene expression patterns in various biological contexts, including cellular differentiation, development, and disease states .

Studies have shown that H2AK5ac often functions in concert with other histone modifications to create specific epigenetic signatures that recruit various chromatin-modifying and transcriptional regulatory complexes. Understanding H2AK5ac patterns and dynamics can provide valuable insights into the mechanisms of gene regulation and chromatin remodeling in both normal and pathological conditions.

What are the validated applications and recommended protocols for Acetyl-Histone H2A (Lys5) Antibody?

Based on the available data, Acetyl-Histone H2A (Lys5) Antibody has been validated for multiple experimental applications with specific recommended protocols:

For Western blotting applications, researchers should extract histones using acid extraction methods to enrich for histone proteins and include HDAC inhibitors (such as sodium butyrate or trichostatin A) in lysis buffers to preserve acetylation marks. When performing immunoprecipitation experiments, it's essential to optimize antibody concentration and incubation conditions to balance between signal strength and background. For immunohistochemistry applications, antigen retrieval methods significantly impact epitope accessibility and staining quality.

What species cross-reactivity has been confirmed for commercially available Acetyl-Histone H2A (Lys5) antibodies?

Commercial antibodies against Acetyl-Histone H2A (Lys5) demonstrate broad species cross-reactivity, making them versatile tools for comparative studies across different model organisms:

How should I design ChIP experiments using Acetyl-Histone H2A (Lys5) Antibody to investigate genome-wide distribution patterns?

Designing effective ChIP experiments with Acetyl-Histone H2A (Lys5) Antibody requires careful consideration of several methodological aspects:

• Chromatin Preparation:

  • Crosslink cells with 1% formaldehyde for 10 minutes at room temperature

  • Quench with 125mM glycine for 5 minutes

  • Lyse cells and sonicate chromatin to 200-500bp fragments (verify size distribution by agarose gel electrophoresis)

  • Include protease inhibitors and HDAC inhibitors in all buffers to preserve protein-DNA interactions and acetylation marks

• Immunoprecipitation Strategy:

  • Use 2-5μg of Acetyl-Histone H2A (Lys5) Antibody per ChIP reaction

  • Include essential controls:

    • Input sample (chromatin before immunoprecipitation)

    • IgG control (non-specific antibody from same species)

    • Positive control (antibody against abundant histone mark like H3K4me3)

  • Incubate antibody-chromatin mixture overnight at 4°C on a rotator

• Washing and Elution:

  • Use increasingly stringent wash buffers to reduce non-specific binding

  • Elute protein-DNA complexes and reverse crosslinks (65°C overnight)

  • Purify DNA using column-based methods for highest recovery

• Analysis Methods:

  • For targeted analysis: qPCR with primers for regions of interest and appropriate normalization to input

  • For genome-wide profiling: ChIP-seq library preparation and high-throughput sequencing

  • For data analysis: use specialized ChIP-seq analysis pipelines (MACS2, Homer) for peak calling and annotation

When interpreting ChIP results, consider that H2AK5ac distribution may vary significantly across different genomic features (promoters, enhancers, gene bodies) and cellular contexts. Integration with other epigenomic and transcriptomic datasets can provide more comprehensive insights into the functional roles of H2AK5ac.

What are the optimal conditions for Western blot analysis to detect H2AK5ac in different cellular contexts?

For robust and reproducible Western blot detection of H2AK5ac, follow these optimized protocols:

• Sample Preparation:

  • Extract histones using acid extraction method (0.2N HCl) for enrichment

  • Add HDAC inhibitors (10mM sodium butyrate, 1μM TSA) to all extraction buffers

  • Quantify protein concentration using Bradford or BCA assays

  • Load 10-20μg of histone extract or 50-100μg of whole cell lysate

• Gel Electrophoresis and Transfer:

  • Use 15-18% SDS-PAGE gels to properly resolve low molecular weight (14 kDa) histone proteins

  • Include molecular weight markers that cover low molecular weight range

  • Transfer to PVDF membrane (preferable over nitrocellulose for small proteins)

  • Optimize transfer conditions: 100V for 1 hour in cold room or 30V overnight

• Antibody Incubation:

  • Block with 5% BSA in TBST (avoid milk, which contains bioactive proteins)

  • Incubate with Acetyl-Histone H2A (Lys5) Antibody at 1:1000 dilution overnight at 4°C

  • Wash thoroughly with TBST (4-5 times, 5-10 minutes each)

  • Incubate with appropriate HRP-conjugated secondary antibody (1:5000-1:10000)

• Controls and Validation:

  • Positive control: lysates from cells treated with HDAC inhibitors

  • Loading control: total H2A antibody or another constitutively expressed protein

  • Peptide competition control to confirm specificity

• Special Considerations for Different Cell Types:

  • Cancer cell lines: May show altered H2AK5ac levels; compare with normal counterparts

  • Primary cells: May require gentler extraction methods; adjust cell numbers

  • Tissue samples: Require additional homogenization steps; increased protease inhibitors

When analyzing Western blot results, quantify band intensities using digital image analysis software and normalize to appropriate loading controls. Report both representative images and quantitative analysis with statistical evaluation of biological replicates.

How can I validate the specificity of Acetyl-Histone H2A (Lys5) Antibody in my experimental system?

Thorough validation of antibody specificity is essential for generating reliable data. For Acetyl-Histone H2A (Lys5) Antibody, implement these validation strategies:

• Peptide Competition Assay:

  • Pre-incubate the antibody with excess synthetic acetylated H2AK5 peptide

  • Compare with antibody pre-incubated with non-acetylated H2A peptide or peptides acetylated at other lysine residues

  • A specific antibody will show signal reduction only with the acetylated H2AK5 peptide

• Genetic Validation:

  • Use CRISPR/Cas9 to generate H2A K5R mutant cells (where lysine is replaced with arginine to prevent acetylation)

  • Compare antibody signal between wild-type and mutant cells

  • The signal should be significantly reduced or absent in K5R mutant cells

• Enzymatic Validation:

  • Treat samples with recombinant histone deacetylases (HDACs)

  • Compare with untreated samples

  • HDAC treatment should decrease H2AK5ac signal if the antibody is specific

• Orthogonal Technique Confirmation:

  • Confirm findings using alternative approaches like mass spectrometry

  • Concordance between methods strengthens confidence in antibody specificity

  • Mass spectrometry can provide unbiased detection of acetylation sites

• Cross-Reactivity Testing:

  • Test antibody against recombinant histones with defined modification patterns

  • Evaluate reactivity against H2A acetylated at other lysine residues (K9, K13, etc.)

  • Assess possible cross-reactivity with acetylated lysines on other histone proteins

By implementing these validation measures, researchers can confidently attribute observed signals to H2AK5ac rather than potential cross-reactivity, ensuring the reliability and reproducibility of their experimental findings.

How do patterns of H2AK5ac correlate with gene expression and other chromatin features?

Interpreting H2AK5ac patterns in relation to gene expression requires nuanced analysis:

When analyzing genome-wide H2AK5ac data, advanced bioinformatic approaches such as correlation analysis, machine learning algorithms, and integrative visualization tools can reveal functional relationships between H2AK5ac and gene regulation that might not be apparent from visual inspection alone.

What is the relationship between H2AK5ac and H2A.Z variant acetylation, and how can I distinguish between them experimentally?

The relationship between canonical H2AK5ac and H2A.Z variant acetylation represents an important distinction in chromatin biology:

• Structural and Functional Differences:

  • H2A.Z is a variant of H2A with approximately 60% sequence identity to canonical H2A

  • H2A.Z incorporation alters nucleosome stability and is enriched at dynamic chromatin regions

  • H2A.Z can be acetylated at multiple lysine residues (K4, K7, K11, and K13)

  • Specific acetylation patterns, such as diacetylation of H2A.Z on K4 and K11, create recognition sites for bromodomain proteins like BPTF

• Genomic Distribution Distinctions:

  • H2A.Z is particularly enriched at:

    • Transcription start sites

    • Enhancers

    • Insulator elements

  • H2A.Z acetylation is often associated with active transcription and chromatin accessibility

  • The distribution pattern of H2A.Z K5ac may differ from canonical H2AK5ac

• Experimental Differentiation Methods:

  • Antibody Selection:

    • Use antibodies that specifically distinguish between canonical H2A and H2A.Z

    • Verify antibody specificity using recombinant proteins and peptide competition assays

  • Sequential ChIP:

    • First ChIP with H2A.Z-specific antibody, then re-ChIP with acetyl-lysine antibody

    • This approach isolates specifically acetylated H2A.Z-containing nucleosomes

  • Mass Spectrometry:

    • Provides definitive identification of specific histone variants and their modifications

    • Can quantify relative abundance of canonical H2AK5ac versus H2A.Z K5ac

• Functional Implications:

  • H2A.Z acetylation may have distinct roles from canonical H2AK5ac

  • The bromodomain protein BPTF shows specific recognition of diacetylated H2A.Z (K4,11), suggesting unique downstream effector recruitment

  • These differences may translate to distinct regulatory outcomes

Understanding the specific roles of canonical versus variant histone acetylation provides deeper insights into the complexity of chromatin-based gene regulation and the histone code.

How does H2AK5ac interact with bromodomain-containing proteins and what are the structural bases for these interactions?

The interaction between H2AK5ac and bromodomain-containing proteins represents a critical mechanism for translating histone modifications into functional outcomes:

• Bromodomain Recognition Mechanism:

  • Bromodomains are specialized protein modules that recognize and bind acetylated lysine residues

  • The acetyl-lysine fits into a hydrophobic pocket within the bromodomain structure

  • Surrounding amino acids influence binding specificity and affinity

  • These interactions typically have dissociation constants in the micromolar range

• Specificity Determinants:

  • The sequence context surrounding K5 influences recognition by specific bromodomains

  • Multiple acetylation sites may create higher-affinity binding through cooperative interactions

  • For H2A.Z, diacetylation at K4 and K11 creates a high-affinity binding site for the BPTF bromodomain with a Kd of 780 μM

  • This suggests that similar patterns may exist for canonical H2AK5ac

• Structural Basis of Recognition:

  • Crystallographic and NMR studies have revealed that bromodomains form a left-handed four-helix bundle

  • The acetyl-lysine binding pocket is formed between two loops (ZA and BC loops)

  • Water molecules often mediate specific hydrogen bonds between the acetyl group and bromodomain residues

  • The histone peptide typically adopts an extended conformation when bound to bromodomains

• Functional Consequences:

  • Bromodomain binding to H2AK5ac can:

    • Recruit chromatin remodeling complexes

    • Stabilize transcription factor binding

    • Facilitate transcriptional elongation

    • Contribute to maintenance of active chromatin states

• Experimental Approaches to Study Interactions:

  • Protein-observed fluorine NMR (PrOF NMR) spectroscopy

  • Isothermal titration calorimetry (ITC)

  • Surface plasmon resonance (SPR)

  • Fluorescence polarization assays

  • Photo-cross-linking experiments with biotin-labeled histone peptides

Understanding these interactions provides mechanistic insights into how H2AK5ac contributes to gene regulation and offers potential targets for therapeutic intervention in diseases involving dysregulated chromatin.

How can I study the dynamics of H2AK5ac during cellular differentiation or disease progression?

Investigating H2AK5ac dynamics during biological processes requires sophisticated experimental approaches:

• Time-Course Experimental Design:

  • Collect samples at multiple time points during differentiation or disease progression

  • Consider both early events (hours) and later stages (days) to capture complete dynamics

  • Include appropriate biological replicates at each time point

  • Parallel collection of samples for multiple analytical techniques

• Multi-Omics Integration:

  • ChIP-seq for H2AK5ac and other relevant histone modifications

  • ATAC-seq for chromatin accessibility changes

  • RNA-seq for transcriptional consequences

  • Proteomics for changes in chromatin-associated proteins

  • Bioinformatic integration of these datasets to identify causal relationships

• Single-Cell Approaches:

  • Single-cell ChIP-seq for heterogeneous populations

  • CUT&Tag or CUT&Run for improved sensitivity with limited material

  • Computational deconvolution of cellular subpopulations

  • Pseudotime analysis to reconstruct temporal dynamics from snapshot data

• Causal Investigation:

  • CRISPR-based manipulation of writers and erasers of H2AK5ac

  • Targeted modulation using dCas9-HAT or dCas9-HDAC fusions

  • Specific inhibition of bromodomain-containing proteins that recognize H2AK5ac

  • Rescue experiments to confirm mechanistic hypotheses

• Visualization Techniques:

  • Immunofluorescence with specific antibodies to track global changes

  • Live-cell imaging with acetylation-sensitive probes

  • Super-resolution microscopy to examine nuclear organization

By applying these approaches, researchers can move beyond correlative observations to establish causal roles for H2AK5ac in cellular processes, potentially identifying new therapeutic targets or diagnostic markers for various diseases.

What are the enzymes responsible for writing and erasing H2AK5ac, and how can I target them experimentally?

Understanding and manipulating the enzymatic regulation of H2AK5ac provides powerful experimental approaches:

• Writers (Histone Acetyltransferases, HATs):

  • Based on studies of H2A.Z, likely enzymes include:

    • GCN5/PCAF (human ortholog of yeast GCN5)

    • TIP60/KAT5 (human ortholog of yeast ESA1)

  • These HATs are typically found in multi-protein complexes that confer specificity

  • MYST family HATs may also contribute to H2AK5 acetylation

• Erasers (Histone Deacetylases, HDACs):

  • Class I HDACs (HDAC1, 2, 3, 8) are primarily involved in histone deacetylation

  • Class III HDACs (Sirtuins) may also play roles in specific contexts

  • HDACs typically function in co-repressor complexes (NuRD, Sin3A, CoREST)

• Experimental Targeting Strategies:

  • Pharmacological Approaches:

    Target Class	Compound	Specificity	Working Concentration
    HAT inhibitors	C646	p300/CBP	1-10 μM
    HAT inhibitors	MB-3	GCN5	100-200 μM
    HDAC inhibitors	Trichostatin A	Pan-HDAC	50-200 nM
    HDAC inhibitors	MS-275	Class I HDACs	1-5 μM

  • Genetic Approaches:

    • siRNA/shRNA for transient or stable knockdown

    • CRISPR-Cas9 for knockout or catalytic dead mutants

    • Inducible expression systems for temporal control

  • Targeted Approaches:

    • CRISPR-dCas9 fused to HATs or HDACs for locus-specific manipulation

    • Chemical-inducible proximity systems for rapid and reversible targeting

• Validation and Analysis Methods:

  • Western blotting to assess global H2AK5ac levels

  • ChIP-seq to determine genomic distribution changes

  • RNA-seq to evaluate functional consequences

  • Mass spectrometry for precise quantification and specificity

By manipulating these enzymatic activities, researchers can establish causal relationships between H2AK5ac and biological processes, potentially identifying therapeutic targets for diseases involving epigenetic dysregulation.

How can I use computational approaches to integrate H2AK5ac data with other epigenomic datasets for a comprehensive understanding of chromatin regulation?

Advanced computational approaches enable deeper insights from integrated epigenomic data:

• Data Integration Pipeline:

  • Align all datasets to the same reference genome

  • Perform consistent quality control and normalization procedures

  • Consider batch effects and technical variability

  • Establish uniform analytical frameworks for cross-dataset comparisons

• Correlation and Co-Localization Analysis:

  • Compute pairwise correlations between H2AK5ac and other epigenetic marks

  • Perform genome-wide co-localization analysis at different genomic features

  • Use tools like DeepTools, ChromHMM, or EpiCSeg to identify chromatin states

  • Apply statistical methods to identify significant associations beyond chance

• Machine Learning Approaches:

  • Use supervised learning to identify predictive relationships:

    • Random forests to identify important features associated with H2AK5ac

    • Support vector machines for classification of regulatory elements

    • Deep learning models for integrating diverse data types

  • Apply unsupervised learning for pattern discovery:

    • Clustering to identify coordinate regulation

    • Dimensionality reduction to visualize complex relationships

• Network Analysis:

  • Construct gene regulatory networks incorporating H2AK5ac data

  • Identify network motifs and regulatory hubs

  • Perform causal inference analysis to establish directional relationships

  • Map H2AK5ac patterns onto protein-protein interaction networks

• Visualization and Interpretation Tools:

  • Genome browsers for locus-specific visualization (UCSC, IGV)

  • Heatmaps and metaplots for aggregate pattern analysis

  • Circos plots for genome-wide interaction visualization

  • Interactive dashboards for exploratory analysis

• Functional Interpretation:

  • Enrichment analysis for genomic features and biological pathways

  • Motif analysis to identify transcription factor associations

  • Comparative genomics to assess evolutionary conservation

  • Integration with phenotypic data to establish functional relevance

These computational approaches transform descriptive epigenomic data into mechanistic insights about chromatin regulation, enabling researchers to generate testable hypotheses about H2AK5ac function in diverse biological contexts.

What are common issues encountered when using Acetyl-Histone H2A (Lys5) Antibody, and how can they be resolved?

Researchers may encounter several technical challenges when working with Acetyl-Histone H2A (Lys5) Antibody:

• Weak or Absent Signal in Western Blots:

  • Possible Causes:

    • Insufficient histone extraction

    • Loss of acetylation marks during sample preparation

    • Antibody degradation or inappropriate storage

    • Suboptimal transfer of low molecular weight histones

  • Solutions:

    • Use acid extraction methods to enrich for histones

    • Add HDAC inhibitors (10mM sodium butyrate, 1μM TSA) to all buffers

    • Store antibody in small aliquots at -20°C or -80°C

    • Optimize transfer conditions for small proteins (higher methanol concentration, lower voltage for longer time)

    • Include positive controls (HDAC inhibitor-treated cells)

• High Background in Immunohistochemistry:

  • Possible Causes:

    • Insufficient blocking

    • Excessive primary or secondary antibody concentration

    • Inadequate washing

    • Non-specific binding to endogenous biotin or peroxidases

  • Solutions:

    • Optimize blocking (try 5% BSA instead of serum)

    • Titrate antibody concentrations

    • Extend wash steps (4-5 washes, 10 minutes each)

    • Include avidin/biotin blocking for biotin-based detection systems

    • Use appropriate quenching for endogenous peroxidases

• Poor Reproducibility in ChIP Experiments:

  • Possible Causes:

    • Inconsistent chromatin fragmentation

    • Variable crosslinking efficiency

    • Batch-to-batch antibody variation

    • Fluctuating H2AK5ac levels due to cell culture conditions

  • Solutions:

    • Standardize sonication conditions and verify fragment size

    • Optimize crosslinking time and formaldehyde concentration

    • Use the same antibody lot for comparative experiments

    • Maintain consistent cell culture conditions (confluence, passage number)

    • Include spike-in controls for normalization

• Cross-Reactivity Issues:

  • Possible Causes:

    • Antibody recognizing other acetylated lysines on H2A or other histones

    • Non-specific binding to other proteins

  • Solutions:

    • Perform peptide competition assays with specific and non-specific peptides

    • Use knockout or mutant controls when possible

    • Validate with orthogonal techniques like mass spectrometry

    • Consider using alternative antibody clones

By systematically addressing these issues, researchers can improve the reliability and reproducibility of experiments using Acetyl-Histone H2A (Lys5) Antibody.

How can I ensure reproducible quantification of H2AK5ac levels across experiments and between different research groups?

Ensuring reproducible quantification of H2AK5ac requires standardized methodologies:

• Sample Preparation Standardization:

  • Document and share detailed protocols for cell culture and treatment conditions

  • Use consistent harvesting methods and timing

  • Prepare all buffers fresh and document composition precisely

  • Process comparative samples simultaneously to minimize batch effects

• Technical Standards for Western Blotting:

  • Include recombinant acetylated standards for calibration curves

  • Use digital imaging systems with linear dynamic range

  • Capture multiple exposures to ensure quantification within linear range

  • Apply consistent background subtraction methods

  • Normalize to total H2A rather than housekeeping proteins

  • Report both raw and normalized data

• ChIP-seq Standardization:

  • Use spike-in controls (e.g., Drosophila chromatin) for normalization

  • Document all bioinformatic parameters:

    • Alignment algorithms and parameters

    • Peak calling methods and thresholds

    • Normalization approaches

  • Make raw data publicly available through repositories

  • Share analytical code through platforms like GitHub

• Antibody Validation and Documentation:

  • Report complete antibody information (manufacturer, catalog number, lot number)

  • Document validation experiments conducted

  • Test for lot-to-lot variation when obtaining new antibody stocks

  • Consider developing community standards for antibody validation

• Statistical Considerations:

  • Determine appropriate sample sizes through power analysis

  • Apply consistent statistical methods for data analysis

  • Report effect sizes alongside p-values

  • Document all exclusion criteria for outliers

• Metadata Documentation:

  • Maintain detailed electronic lab notebooks

  • Document all experimental conditions and deviations from protocols

  • Use consistent terminology and units of measurement

  • Adhere to community-established reporting standards

By implementing these practices, researchers can enhance the reproducibility of H2AK5ac quantification, facilitating cross-laboratory comparisons and building more reliable scientific knowledge.

What is the best way to differentiate between specific H2AK5ac signal and antibody cross-reactivity with other histone acetylation marks?

Distinguishing specific H2AK5ac signal from potential cross-reactivity requires rigorous validation:

• Peptide Competition Assays:

  • Test antibody specificity by pre-incubation with:

    • Acetylated H2AK5 peptides (should block specific binding)

    • Unmodified H2A peptides (should not affect specific binding)

    • H2A peptides acetylated at other positions (K9, K13, etc.)

    • Acetylated peptides from other histones

  • A truly specific antibody will show signal reduction only with the acetylated H2AK5 peptide

• Genetic Validation Approaches:

  • Use CRISPR/Cas9 to generate:

    • H2A K5R mutant cells (prevents acetylation at this site)

    • Cells with mutations at other potential cross-reactive sites

  • Compare signal patterns between wild-type and mutant cells

  • The specific signal should be absent or significantly reduced in K5R mutants only

• Enzymatic Approaches:

  • Treat samples with site-specific histone deacetylases when available

  • Use recombinant HDACs with known specificity profiles

  • Compare with broad-spectrum HDAC treatment

  • Pattern of signal reduction provides insights into antibody specificity

• Mass Spectrometry Validation:

  • Use parallel mass spectrometry analysis as gold standard

  • Immunoprecipitate with the antibody and analyze by MS

  • Verify presence of H2AK5ac in the immunoprecipitated material

  • Check for co-enrichment of other modifications

• Cross-Platform Validation:

  • Compare results across different applications (ChIP, Western blot, IHC)

  • Consistent patterns across platforms increase confidence in specificity

  • Discrepancies may reveal context-dependent cross-reactivity